A novel water-soluble fluorescent probe with ultra-sensitivity over a wider pH range and its application for differentiating cancer cells from normal cells

The Analyst ◽  
2019 ◽  
Vol 144 (23) ◽  
pp. 6975-6980 ◽  
Author(s):  
Zilu Li ◽  
Chen Yu ◽  
Yanan Chen ◽  
Zihan Zhuang ◽  
Bin Tian ◽  
...  

A water-soluble fluorescent probe with ultra-sensitivity over a wider pH range was developed to differentiate cancer cells from normal cells.

2019 ◽  
Vol 7 (43) ◽  
pp. 6822-6827 ◽  
Author(s):  
Fanpeng Kong ◽  
Ying Li ◽  
Chao Yang ◽  
Xiao Li ◽  
Junlin Wu ◽  
...  

A dual-enzyme-responsive probe, CNN, was rationally designed and synthesized for differentiating cancer cells from normal cells owing to the existence of relatively high endogenous levels of both biomarkers in cancer cells.


RSC Advances ◽  
2020 ◽  
Vol 10 (56) ◽  
pp. 33635-33641
Author(s):  
Meihua Lin ◽  
Xin Ma ◽  
Shijun Lin ◽  
Xiaojin Zhang ◽  
Yu Dai ◽  
...  

N-doped carbon dots used as a fluorescence probe can distinguish cancer cells from normal cells by pH and evaluate intracellular GSH.


The Analyst ◽  
2019 ◽  
Vol 144 (23) ◽  
pp. 7010-7016 ◽  
Author(s):  
Hanchuang Zhu ◽  
Hanming Zhang ◽  
Changxu Liang ◽  
Caiyun Liu ◽  
Pan Jia ◽  
...  

The efficient discrimination of cancer cells from normal cells was achieved with a novel highly sensitive biothiol-specific fluorescent probe.


2018 ◽  
Vol 6 (27) ◽  
pp. 4514-4521 ◽  
Author(s):  
Arup Podder ◽  
Sudipta Senapati ◽  
Pralay Maiti ◽  
Devaraj Kamalraj ◽  
Syed S Jaffer ◽  
...  

A turn-on fluorescent probe (LP1) discriminates cancer cells from normal cells based on expression of phosphatase in lysosomes.


2020 ◽  
Vol 56 (93) ◽  
pp. 14613-14616
Author(s):  
Weijie Zhang ◽  
He Wang ◽  
Feng Li ◽  
Yuncong Chen ◽  
Ryan T. K. Kwok ◽  
...  

A high performance ratiometric fluorescent probe, namely TPE-RNS, has been developed for detecting exogenous and endogenous HClO/ClO− in living cells and discriminating cancer cells from normal cells.


2021 ◽  
Author(s):  
Arup Podder ◽  
Manu M. Joseph ◽  
Shayeri Biswas ◽  
Sanjib Samanta ◽  
Kaustabh K. Maiti ◽  
...  

Newly developed an amphiphilic “turn-on” fluorescent probe (P1CS) enables to distinguish of cancer cells from normal cells through mapping of pH fluctuations in cell-surface.


2019 ◽  
Vol 43 (20) ◽  
pp. 7874-7880 ◽  
Author(s):  
Xiaozheng Cao ◽  
Tang Gao ◽  
Jie Dong ◽  
Xinchen Jiang ◽  
Hui Zou ◽  
...  

The first AIE-based fluorescent probe TPI-IMC was developed for imaging of cyclooxygenase-2 (COX-2) in normal cells and cancer cells.


Biomolecules ◽  
2019 ◽  
Vol 9 (9) ◽  
pp. 411 ◽  
Author(s):  
Sylwia Michlewska ◽  
Małgorzata Kubczak ◽  
Marta Maroto-Díaz ◽  
Natalia Sanz del Olmo ◽  
Paula Ortega ◽  
...  

Metallodendrimers—dendrimers with included metals—are widely investigated as biocompatible equivalents to metal nanoparticles. Applications can be expected in the fields of catalysis, as chemical sensors in molecular recognition and as anticancer drugs. Metallodendrimers can also mimic certain biomolecules, for example, haemoprotein in the case of using a dendrimer with a porphyrin core. In previous papers, we showed the promising anticancer effects of carbosilane ruthenium dendrimers. The present paper is devoted to studying biocompatibility and the cytotoxic effect on normal and cancer cells of carbosilane ruthenium dendrimers labelled with fluorescent probe fluorescein isothiocyanate (FITC). The addition of fluorescent probe allowed tracking the metallodendrimer in both normal and cancer cells. It was found that carbosilane ruthenium dendrimer labelled with FITC in concentration up to 10 µmol/L was more cytotoxic for cancer cells than for normal cells. Thus, FITC labelled carbosilane ruthenium dendrimer is a good candidate for diagnostic imaging and studying anticancer effects of metallodendrimers in cancer therapy.


2020 ◽  
Vol 56 (74) ◽  
pp. 10902-10905
Author(s):  
Ruijin Huo ◽  
Xiuli Zheng ◽  
Weimin Liu ◽  
Liping Zhang ◽  
Jiasheng Wu ◽  
...  

A GGT-activated two-photon fluorescent probe was developed for distinguishing ovarian cancer cells from normal cells.


RSC Advances ◽  
2016 ◽  
Vol 6 (80) ◽  
pp. 76600-76613 ◽  
Author(s):  
Ishani Mitra ◽  
Subhajit Mukherjee ◽  
Venkata P. Reddy B. ◽  
Subrata Dasgupta ◽  
Jagadeesh C. Bose K ◽  
...  

Water soluble Pt(ii) complexes with higher viability towards normal cells and comparable cytotoxicity to cancer cells as compared to cisplatin.


Sign in / Sign up

Export Citation Format

Share Document